Dongxu Yi

Title: Dongxu Yi: Innovator in Pharmaceutical Crystallization

Introduction

Dongxu Yi is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical crystallization, holding a total of 5 patents. His work focuses on improving the stability and purity of pharmaceutical compounds, which is crucial for their effectiveness and safety.

Latest Patents

Dongxu Yi's latest patents include innovative formulations that enhance the stability of pharmaceutical compounds. One of his notable patents is for a crystalline form A of 2,2-bis(4-fluorophenyl)-2-phenylacetamide. This crystalline form exhibits excellent light stability, high temperature stability, and high humidity stability. Another significant patent is for the eutectic form A of Elagolix and pyrimethamine. This formulation demonstrates high purity and stability under various conditions, making it suitable for large-scale industrial production.

Career Highlights

Throughout his career, Dongxu Yi has worked with several companies, including Shenzhen Rentai Pharmatech Ltd and Shenzhen Jingtai Technology Co., Ltd. His experience in these organizations has allowed him to refine his skills in pharmaceutical development and crystallization techniques.

Collaborations

Dongxu Yi has collaborated with notable professionals in his field, including Guobin Ren and Jiajun Huang. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Dongxu Yi is a distinguished inventor whose work in pharmaceutical crystallization has led to significant advancements in the field. His innovative patents reflect his commitment to improving the stability and efficacy of pharmaceutical compounds.